{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:16:33Z","timestamp":1747973793142,"version":"3.41.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL155915"],"award-info":[{"award-number":["R01-HL155915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijcha.2025.101663","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T06:48:21Z","timestamp":1744699701000},"page":"101663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Associations between pathophysiological traits and symptom development in retrospective analysis of V30M and V122I transthyretin amyloidosis"],"prefix":"10.1016","volume":"58","author":[{"given":"Sameer U.","family":"Kini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha","family":"My Thi Vy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhav","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parasuram M.","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Son Q.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislain","family":"Rocheleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagat","family":"Narula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish N.","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijcha.2025.101663_b0005","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.ijcha.2025.101663_b0010","doi-asserted-by":"crossref","first-page":"e003356","DOI":"10.1161\/CIRCGEN.121.003356","article-title":"Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: a systematic review","volume":"14","author":"Chandrashekar","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","article-title":"Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations","volume":"26","author":"Conceicao","year":"2019","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2020.04.074","article-title":"V122I transthyretin cardiomyopathy: an opportunity to build trust and resolve disparities","volume":"76","author":"Sher","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2025.101663_b0025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41431-019-0337-1","article-title":"Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data","volume":"27","author":"Pueyo","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101663_b0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10741-021-10098-6","article-title":"Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review","volume":"27","author":"Goyal","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101663_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"26","key":"10.1016\/j.ijcha.2025.101663_b0040","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/bi800636q","article-title":"Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis","volume":"47","author":"Hurshman Babbes","year":"2008","journal-title":"Biochemistry"},{"issue":"17","key":"10.1016\/j.ijcha.2025.101663_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179488","article-title":"In vitro and in vivo effects of serpina1 on the modulation of transthyretin proteolysis","volume":"22","author":"Bezerra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"407","key":"10.1016\/j.ijcha.2025.101663_b0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7621","article-title":"Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients","volume":"9","author":"Schonhoft","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/bmc-2013-0038","article-title":"Transthyretin: a multifaceted protein","volume":"5","author":"Vieira","year":"2014","journal-title":"Biomol. Concepts"},{"issue":"29","key":"10.1016\/j.ijcha.2025.101663_b0060","doi-asserted-by":"crossref","first-page":"E6741","DOI":"10.1073\/pnas.1805131115","article-title":"Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition","volume":"115","author":"Saelices","year":"2018","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jns.12153","article-title":"\u201cRed-flag\u201d symptom clusters in transthyretin familial amyloid polyneuropathy","volume":"21","author":"Conceicao","year":"2016","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101663_b0070","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijcha.2025.101663_b0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101663_b0080","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/labinvest.3780116","article-title":"Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation","volume":"80","author":"Sousa","year":"2000","journal-title":"Lab. Invest."},{"issue":"19","key":"10.1016\/j.ijcha.2025.101663_b0085","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","article-title":"Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways","volume":"21","author":"Sousa","year":"2001","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ijcha.2025.101663_b0090","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016072118","article-title":"A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction","volume":"118","author":"Jiang","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.ijcha.2025.101663_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.949401","article-title":"The frequency of V122I transthyretin mutation in a cohort of African American individuals with bilateral carpal tunnel syndrome","volume":"13","author":"Shije","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0100","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140155","article-title":"Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage","volume":"35","author":"Manral","year":"2015","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101663_b0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2016.200","article-title":"Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans","volume":"19","author":"Buxbaum","year":"2017","journal-title":"Genet. Med."},{"issue":"22","key":"10.1016\/j.ijcha.2025.101663_b0110","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2019.17935","article-title":"Association of the V122I hereditary transthyretin amyloidosis genetic variant with heart failure among individuals of African or Hispanic\/Latino ancestry","volume":"322","author":"Damrauer","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijcha.2025.101663_b0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.amjcard.2022.06.048","article-title":"Hereditary transthyretin amyloidosis cardiomyopathy: the South Florida experience","volume":"180","author":"Trujillo","year":"2022","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcha.2025.101663_b0120","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson Michelle","year":"2023","journal-title":"JACC"},{"issue":"5","key":"10.1016\/j.ijcha.2025.101663_b0125","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s10741-021-10164-z","article-title":"The genetics of cardiac amyloidosis","volume":"27","author":"Arno","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0130","doi-asserted-by":"crossref","first-page":"e003011","DOI":"10.1161\/CIRCGEN.120.003011","article-title":"Epigenomic profiles of African-American transthyretin Val122Ile carriers reveals putatively dysregulated amyloid mechanisms","volume":"14","author":"Pathak","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0135","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1038\/s41598-021-91113-6","article-title":"Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry","volume":"11","author":"Parker","year":"2021","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101663_b0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126526","article-title":"Predictive model of response to tafamidis in hereditary ATTR polyneuropathy","volume":"4","author":"Monteiro","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101663_b0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2020.1744553","article-title":"The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease","volume":"27","author":"Azevedo Coutinho","year":"2020","journal-title":"Amyloid"},{"issue":"11","key":"10.1016\/j.ijcha.2025.101663_b0150","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.7150\/thno.14584","article-title":"Peripheral blood cell gene expression diagnostic for identifying symptomatic transthyretin amyloidosis patients: male and female specific signatures","volume":"6","author":"Kurian","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ijcha.2025.101663_b0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101663_b0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcha.2025.101663_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-0716-0327-7_19","article-title":"Cell-type enrichment analysis of bulk transcriptomes using xCell","volume":"2120","author":"Aran","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijcha.2025.101663_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"GigaScience"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101663_b0175","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.amjmed.2020.06.031","article-title":"Low prevalence of clinically apparent cardiac amyloidosis among carriers of transthyretin V122I variant in a large electronic medical record","volume":"134","author":"Agbor-Etang","year":"2021","journal-title":"Am. J. Med."},{"issue":"16","key":"10.1016\/j.ijcha.2025.101663_b0180","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","article-title":"R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment","volume":"30","author":"Carroll","year":"2014","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.ijcha.2025.101663_b0185","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcha.2025.101663_b0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"issue":"5","key":"10.1016\/j.ijcha.2025.101663_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the caret Package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.ijcha.2025.101663_b0200","unstructured":"T. Therneau, A Package for Survival Analysis in R. R package version 3.4-0. 2022."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101663_b0205","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ehjci\/jet284","article-title":"Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study","volume":"15","author":"Kou","year":"2014","journal-title":"Europ. Heart J. \u2013 Cardiovasc. Imag."},{"key":"10.1016\/j.ijcha.2025.101663_b0210","article-title":"The role of inflammation in amyloid diseases","author":"Azevedo","year":"2018","journal-title":"Amyloid Dis."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0215","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/s41598-017-01775-4","article-title":"Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin","volume":"7","author":"Suenaga","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12883-019-1369-4","article-title":"Inflammatory profiling of patients with familial amyloid polyneuropathy","volume":"19","author":"Azevedo","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ijcha.2025.101663_b0225","first-page":"6","article-title":"Amyloid proteins and peripheral neuropathy","volume":"9","author":"Asiri","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ijcha.2025.101663_b0230","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijcha.2025.101663_b0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjcard.2020.12.015","article-title":"Prediction of incident heart failure in TTR Val122Ile carriers one year ahead of diagnosis in a multiethnic biobank","volume":"142","author":"Chaudhary","year":"2021","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0240","doi-asserted-by":"crossref","first-page":"H83","DOI":"10.1530\/VB-19-0023","article-title":"The crosstalk between the cardiovascular and the immune system","volume":"1","author":"Lin","year":"2019","journal-title":"Vasc. Biol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101663_b0245","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/ATVBAHA.117.307263","article-title":"22016 ATVB plenary lecture: receptor for advanced glycation endproducts and implications for the pathogenesis and treatment of cardiometabolic disorders: spotlight on the macrophage","volume":"37","author":"Schmidt","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0250","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00415-014-7594-2","article-title":"Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient","volume":"262","author":"McColgan","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijcha.2025.101663_b0255","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2017.09.001","article-title":"Ocular manifestations of familial transthyretin amyloidosis","volume":"183","author":"Reynolds","year":"2017","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101663_b0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/13506129.2015.1015678","article-title":"Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases","volume":"22","author":"Beirao","year":"2015","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101663_b0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/13506129.2021.2018678","article-title":"The integration of genetically-regulated transcriptomics and electronic health records highlights a pattern of medical outcomes related to increased hepatic transthyretin expression","volume":"29","author":"Pathak","year":"2022","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.ijcha.2025.101663_b0270","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/acel.12665","article-title":"Transthyretin deposition promotes progression of osteoarthritis","volume":"16","author":"Matsuzaki","year":"2017","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0275","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1631\/jzus.B1300046","article-title":"Clinical and laboratory characteristics of patients having amyloidogenic transthyretin deposition in osteoarthritic knee joints","volume":"15","author":"Gu","year":"2014","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/13506129.2015.1115758","article-title":"Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid","volume":"23","author":"Yanagisawa","year":"2016","journal-title":"Amyloid"},{"issue":"11","key":"10.1016\/j.ijcha.2025.101663_b0285","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101663_b0290","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s12350-020-02467-9","article-title":"Incidental detection of ATTR cardiac amyloidosis","volume":"29","author":"Quaggin-Smith","year":"2022","journal-title":"J. Nucl. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcha.2025.101663_b0295","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00439-019-02078-6","article-title":"Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses","volume":"138","author":"De Lillo","year":"2019","journal-title":"Hum. Genet."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101663_b0300","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/13506129.2013.845745","article-title":"Genotype, echocardiography, and survival in familial transthyretin amyloidosis","volume":"20","author":"Arruda-Olson","year":"2013","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101663_b0305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCHEARTFAILURE.109.910455","article-title":"Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: transthyretin Cardiac Amyloid Study (TRACS)","volume":"4","author":"Bhuiyan","year":"2011","journal-title":"Circ. Heart Fail."},{"issue":"21","key":"10.1016\/j.ijcha.2025.101663_b0310","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1136\/heartjnl-2012-301924","article-title":"Cardiac transthyretin amyloidosis","volume":"98","author":"Dungu","year":"2012","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101663_b0315","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ahj.2012.04.015","article-title":"Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)","volume":"164","author":"Ruberg","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2025.101663_b0320","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","author":"Damy","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101663_b0325","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/clc.23572","article-title":"Cardiac amyloidosis-A review of current literature for the practicing physician","volume":"44","author":"Ash","year":"2021","journal-title":"Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14797\/mdcj-11-1-53","article-title":"Case report: isolated cardiac amyloidosis: an enigma unravelled","volume":"11","author":"Khalid","year":"2015","journal-title":"Methodist Debakey Cardiovasc. J."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101663_b0335","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ejhf.2200","article-title":"Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans","volume":"23","author":"Minamisawa","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0340","first-page":"e21481","article-title":"A late diagnosis of transthyretin amyloidosis","volume":"14","author":"Pfirman","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101663_b0345","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ncpcardio1423","article-title":"Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutation","volume":"6","author":"Wechalekar","year":"2009","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"19","key":"10.1016\/j.ijcha.2025.101663_b0350","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ijcha.2025.101663_b0355","unstructured":"A.V. Delicce, A.N. Makaryus, Physiology, Frank Starling Law, in StatPearls. 2022: Treasure Island (FL)."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101663_b0360","doi-asserted-by":"crossref","first-page":"137","DOI":"10.14740\/jocmr2050w","article-title":"Left ventricular diastolic function in hypertension: methodological considerations and clinical implications","volume":"7","author":"Palmiero","year":"2015","journal-title":"J. Clin. Med. Res."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101663_b0365","first-page":"191","article-title":"Clinical implications of left atrial enlargement: a review","volume":"9","author":"Patel","year":"2009","journal-title":"Ochsner J."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101663_b0370","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101663_b0375","doi-asserted-by":"crossref","first-page":"e009746","DOI":"10.1161\/CIRCIMAGING.119.009746","article-title":"Left atrial end-diastolic volume index as a predictor of cardiovascular outcomes: the heart and soul study","volume":"13","author":"Thadani","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"24","key":"10.1016\/j.ijcha.2025.101663_b0380","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"JACC"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0385","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13023-023-02962-5","article-title":"A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"18","author":"Gentile","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ijcha.2025.101663_b0390","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003352","article-title":"Afro-Caribbean heart failure in the United Kingdom: cause, outcomes, and ATTR V122I cardiac amyloidosis","volume":"9","author":"Dungu","year":"2016","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101663_b0395","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/humu.23669","article-title":"Analysis of the TTR gene in the investigation of amyloidosis: a 25-year single UK center experience","volume":"40","author":"Rowczenio","year":"2019","journal-title":"Hum. Mutat."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:38:12Z","timestamp":1747928292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":79,"alternative-id":["S2352906725000661"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101663","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between pathophysiological traits and symptom development in retrospective analysis of V30M and V122I transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101663"}}